210O Mutational signature analysis reveals patterns of genomic instability linked to resistance to endocrine therapy (ET) +/- CDK 4/6 inhibition (CDK4/6i) in estrogen receptor-positive/HER2-negative (ER+/HER2-) metastatic breast cancer (MBC)

Marra, A. ; Gazzo, A. ; Gupta, A. ; Selenica, P. ; Da Silva, E.M. ; Pareja, F. ; Pei, X. ; Zhu, Y. ; Razavi, P. ; Safonov, A. ; Ferraro, E. ; Harris, R. ; Riaz, N. ; Reis-Filho, J.S. ; Chandarlapaty, S.

Annals of oncology, 2022-09, Vol.33, p.S632 [Periódico revisado por pares]

Texto completo disponível